Skip to content

Research on the repeatability of measuring tissue properties with MRI

Test-retest validation of quantitative MRI in healthy volunteers - test-retest MRI in healthy volunteers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49913
Enrollment
208
Registered
2021-06-22
Start date
2021-11-16
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none, healthy volunteers are accrued for control of diagnostics in cancer patients

Interventions

Magnetic Resonance Imaging

Sponsors

Antoni van Leeuwenhoek (AVL)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Volunteer, age >= 18 years, willing to be scanned two times within a couple of weeks apart. • Ability to understand and the willingness to sign a written informed consent and a safety screening document

Exclusion criteria

Exclusion criteria: • Contra-indications for an MRI examination. • Pregnancy. • Claustrophobia. • Any clinically significant medical condition which, in the opinion of the  researchers, makes it undesirable to participate in the study or which could  jeopardize compliance with study requirements or severe psychiatric  illness/social situation. • refusal to be informed about incidental findings on the MRI.  Additional in- and exclusion criteria may apply to specific techniques and are  listed in the technique specific study manuals provided. When these criteria  differ from those listed here, the technique specific in/exclusion criteria  will take precedence

Design outcomes

Primary

MeasureTime frame
The main study parameter is the repeatability coefficient (within-coefficient of variance) between the qMRI values measured during the test and retest

Countries

Netherlands

Contacts

Public ContactM.E. Nowee

Antoni van Leeuwenhoek (AVL)

RTstudieondersteuning@nki.nl0205129111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)